Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $40.13MP/E –Yield –
Harvard Apparatus Regenerative Technology gross margin
Gross margin is gross profit as a percentage of revenue.
Harvard Apparatus Regenerative Technology's gross margin for the twelve months ending Sep 30, 2026 was 7.5%. For fiscal 2025 it was 8.2%, against 37.2% the year before. The highest annual figure on record is 76.7% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.2% | −29.0 |
| FY2024 | Dec 31, 2024 | 37.2% | −39.5 |
| FY2023 | Dec 31, 2023 | 76.7% | +118.2 |
| FY2016 | Dec 31, 2016 | -41.5% | −23.7 |
| FY2015 | Dec 31, 2015 | -17.8% | −66.2 |
| FY2014 | Dec 31, 2014 | 48.4% | −1.6 |
| FY2013 | Dec 31, 2013 | 50.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 8.3% | −0.7 |
| Q2 FY2026 | Jun 30, 2026 | 5.6% | +0.8 |
| Q1 FY2026 | Mar 31, 2026 | 8.8% | −17.8 |
| Q4 FY2025 | Dec 31, 2025 | 9.1% | −23.0 |
| Q3 FY2025 | Sep 30, 2025 | 8.9% | +27.6 |
| Q2 FY2025 | Jun 30, 2025 | 4.7% | −72.1 |
| Q1 FY2025 | Mar 31, 2025 | 26.7% | −52.3 |
| Q4 FY2024 | Dec 31, 2024 | 32.2% | +142.9 |
| Q3 FY2024 | Sep 30, 2024 | -18.6% | – |
| Q2 FY2024 | Jun 30, 2024 | 76.8% | – |
| Q1 FY2024 | Mar 31, 2024 | 78.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -110.7% | – |
See a number that looks wrong?